Lorna Rothery discussed the challenges associated with the safe transfusion and supply of blood with Dr Evan M. Bloch, focusing on where future efforts to reduce transfusion-transmitted infections should be directed.
Researchers from the University of Oxford and their partners have reported that the malaria vaccine, R21/Matrix-M, has demonstrated high-level efficacy of 77%.
Open Access Government explores the health priorities of Stella Kyriakides, Commissioner for Health and Food Safety, asking if lessons learned from the ongoing COVID-19 pandemic can help to improve European healthcare?.
There is little mainstream awareness of the condition that impacts one in ten women - currently, 30% of people with Polycystic ovary syndrome (PCOS) rely on online forums for information.
Professor Paramala Santosh, CEO of HealthTracker Ltd, co-developed the HealthTrackerTM platform – developed by clinicians, assisted by patients for patients, clinicians & researchers, more of which we learn about here.
Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.
Dr Shireen Kassam MBBS, FRCPath, PhD, dipIBLM, Founder and Director of Plant-Based Health Professionals UK, explains a simple prescription for health as a remedy to chronic disease.
Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, highlights how immunotherapy is raising hopes for the next big breakthrough in type 1 diabetes.
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill, writes in detail about plague, the first pandemic disease including comment on bacteria.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, explains how the COVID-19 pandemic is the scenario for testing and demonstrating the successful implementation of diabetes telehealth platforms.
Chief Talent & Global Strategy Officer Dr Dianne Morrison-Beedy highlights the major issue of how adolescent girls from refugee backgrounds have been forgotten in evidence-based sexual risk reduction interventions.
The Medicines Manufacturing Innovation Centre (MMIC) has developed a scalable, sustainable and more cost-effective way to manufacture oligonucleotides and treat rare diseases.
![Figure 1: Sketch of the evolution of the Universe over the last 13.77 billion years. It started with the Big Bang, followed by an extremely short period of rapid exponential expansion. The furthest we can see is the cosmic microwave background, when radiation decoupled from matter, approximately 380,000 years after the Big Bang. This is followed by the ‘dark ages,’ during which this radiation redshifted from the visible regime into infrared and sub-mm wavelengths. The occurrence of the first stars, about 400 million years after the Big Bang, ended this phase, spearheading the formation of galaxies as we see them today. [Credit: NASA/WMAP Science Team, public domain]](https://www.openaccessgovernment.org/wp-content/uploads/2025/05/Fig-1_1200.jpg)
